Intraocular pressure elevation following triamcinolone acetonide administration as related to administration routes

Japanese Journal of Ophthalmology

Volumn 53, Issue 5, 2009, Pages 519-522

  Hirano, Yoshio ^a   Ito, Takeshi ^a   Nozaki, Miho ^a   Yasukawa, Tsutomu ^a   Sakurai, Eiji ^a   Yoshida, Munenori ^a   Ogura, Yuichiro ^a  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

Author keywords

Intraocular pressure elevation; Risk factor; Steroid glaucoma; Triamcinolone acetonide

Indexed keywords

ANTIGLAUCOMA AGENT; TRIAMCINOLONE ACETONIDE;

ADULT; AGED; ARTICLE; BRANCH RETINAL VEIN OCCLUSION; CENTRAL RETINA VEIN OCCLUSION; DIABETIC MACULAR EDEMA; HUMAN; INCIDENCE; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; RETROSPECTIVE STUDY; RISK FACTOR; SIDE EFFECT; SUBRETINAL NEOVASCULARIZATION; UVEITIS;

ADULT; AGED; AGED, 80 AND OVER; ANTIHYPERTENSIVE AGENTS; DRUG ADMINISTRATION ROUTES; FEMALE; GLUCOCORTICOIDS; HUMANS; INCIDENCE; INJECTIONS; INTRAOCULAR PRESSURE; MALE; MIDDLE AGED; OCULAR HYPERTENSION; RETINAL DISEASES; RETROSPECTIVE STUDIES; RISK FACTORS; TONOMETRY, OCULAR; TRABECULECTOMY; TRIAMCINOLONE ACETONIDE;

EID: 77749286436     PISSN: 00215155     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10384-009-0692-5     Document Type: Article

References (25)

1. J.B. Jonas I. Kreissig R.F. Degenring 2003 Intravitreal triamcinolone acetonide for pseudophakic cystoid macular edema Am J Ophthalmol 136 384 386 10.1016/S0002-9394(03)00230-7 1:CAS:528:DC%2BD3sXlvVWmtbc%3D 12888077 (Pubitemid 36904101)
2. A.A. Okada T. Wakabayashi Y. Morimura, et al. 2003 Trans-Tenon's retrobulbar triamcinolone infusion for the treatment of uveitis Br J Ophthalmol 87 968 971 10.1136/bjo.87.8.968 1:STN:280:DC%2BD3szkvVCqsw%3D%3D 12881336 (Pubitemid 36936292)
3. R.J. Antcliff D.J. Spalton M.R. Stanford, et al. 2001 Intravitreal triamcinolone for uveitic cystoid macular edema: an optical coherence tomography study Ophthalmology 108 765 772 10.1016/S0161-6420(00)00658-8 1:STN:280:DC%2BD3M3gvVOltA%3D%3D 11297495 (Pubitemid 32238474)
4. R.F. Spaide J. Sorenson L. Maranan 2003 Combined photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide for choroidal neovascularization Ophthalmology 110 1517 1525 10.1016/S0161-6420(03)00544-X 12917166 (Pubitemid 36962483)
5. J.B. Jonas I. Kreissig A. Sofker, et al. 2003 Intravitreal injection of triamcinolone for diffuse diabetic macular edema Arch Ophthalmol 121 57 61 10.1001/archopht.121.5.729 1:CAS:528:DC%2BD3sXps1KqsQ%3D%3D 12523885 (Pubitemid 36554480)
6. C.H. Park G.J. Jaffe S. Fekrat 2003 Intravitreal triamcinolone acetonide in eyes with cystoid macular edema associated with central retinal vein occlusion Am J Ophthalmol 136 419 425 10.1016/S0002-9394(03)00228-9 1:CAS:528:DC%2BD3sXntVKitL8%3D 12967793 (Pubitemid 37101237)
7. S.D. Chen J. Lochhead C.K. Patel, et al. 2004 Intravitreal triamcinolone acetonide for ischaemic macular edema caused by branch retinal vein occlusion Br J Ophthalmol 88 154 155 10.1136/bjo.88.1.154 1:CAS:528:DC%2BD2cXotVGksrw%3D 14693796 (Pubitemid 38091385)
8. J.B. Jonas I. Akkoyun B. Kamppeter, et al. 2005 Branch retinal vein occlusion treated by intravitreal triamcinolone acetonide Eye 19 65 71 10.1038/sj.eye.6701395 1:CAS:528:DC%2BD2MXovVWh 15105817 (Pubitemid 40192642)
9. J.B. Jonas I. Kreissig R. Degenring 2003 Intraocular pressure after intravitreal injection of triamcinolone acetonide Br J Ophthalmol 87 24 27 10.1136/bjo.87.1.24 1:STN:280:DC%2BD38jisFGgsA%3D%3D 12488256 (Pubitemid 36071773)
10. S.J. Bakri P.M. Beer 2003 The effect of intravitreal triamcinolone acetonide on intraocular pressure Ophthalmic Surg Lasers Imaging 34 386 390 14509462
11. P. Massin F. Audren B. Haouchine, et al. 2004 Intravitreal triamcinolone acetonide for diabetic diffuse macular edema Ophthalmology 111 218 224 10.1016/j.ophtha.2003.05.037 15019365 (Pubitemid 38183217)
12. I.P. Singh S.I. Ahmad D. Yeh, et al. 2004 Early rapid rise in intraocular pressure after intravitreal triamcinolone acetonide injection Am J Ophthalmol 138 286 287 10.1016/j.ajo.2004.03.001 15289140 (Pubitemid 39037435)
13. L.M. Smithen M.D. Ober L. Maranan, et al. 2004 Intravitreal triamcinolone acetonide and intraocular pressure Am J Ophthalmol 138 740 743 10.1016/j.ajo.2004.06.067 1:CAS:528:DC%2BD2cXpsVOkurc%3D 15531307 (Pubitemid 39452920)
14. D.S. Levin D.P. Han S. Dev, et al. 2002 Subtenon's depot corticosteroid injections in patients with a history of corticosteroid-induced intraocular pressure elevation Am J Ophthalmol 133 196 202 10.1016/S0002-9394(01)01372-1 1:CAS:528:DC%2BD38XmsFyqug%3D%3D 11812422 (Pubitemid 34072047)
15. A.J. Mueller G. Jian A.S. Banker, et al. 1998 The effect of deep posterior subtenon injection of corticosteroids on intraocular pressure Am J Ophthalmol 125 158 163 10.1016/S0002-9394(99)80085-3 1:CAS:528: DyaK1MXkvV2ksbY%3D 9467440 (Pubitemid 28081292)
16. D.M. Moshfeghi P.K. Kaiser I.U. Scott, et al. 2003 Acute endophthalmitis following intravitreal triamcinolone acetonide injection Am J Ophthalmol 136 791 796 10.1016/S0002-9394(03)00483-5 1:CAS:528:DC%2BD3sXosVyks78%3D 14597028 (Pubitemid 37330020)
17. J.B. Jonas R.F. Degenring I. Kreissig, et al. 2005 Intraocular pressure elevation after intravitreal triamcinolone acetonide injection Ophthalmology 112 593 598 10.1016/j.ophtha.2004.10.042 15808249
18. K. Iwao M. Inatani T. Kawaji, et al. 2007 Frequency and risk factors for intraocular pressure elevation after posterior sub-Tenon capsule triamcinolone acetonide injection J Glaucoma 16 251 256 10.1097/IJG.0b013e31802d696f 17473740 (Pubitemid 46673362)
19. D. Shukla N. Vidhya N.M. Prasad, et al. 2007 Evaluation of patient age as a risk factor for intraocular pressure elevation after intravitreal triamcinolone Am J Ophthalmol 144 453 454 10.1016/j.ajo.2007.04.021 1:CAS:528:DC%2BD2sXpvF2ru7s%3D 17765428 (Pubitemid 47331385)
20. Y. Yamamoto T. Komatsu Y. Koura, et al. 2008 Intraocular pressure elevation after intravitreal or posterior sub-Tenon triamcinolone acetonide injection Can J Ophthalmol 43 42 47 10.3129/I07-186 18204501 (Pubitemid 351269567)
21. M. Inatani K. Iwao T. Kawaji, et al. 2008 Intraocular pressure elevation after injection of triamcinolone acetonide: a multicenter retrospective case-control study Am J Ophthalmol 145 676 681 10.1016/j.ajo.2007.12.010 1:CAS:528:DC%2BD1cXjs1Srs78%3D 18243153
22. L.I. Lau K.C. Chen F.L. Lee, et al. 2008 Intraocular pressure elevation after intravitreal triamcinolone acetonide injection in a Chinese population Am J Ophthalmol 146 573 578 10.1016/j.ajo.2008.05.034 1:CAS:528:DC%2BD1cXhtFektbfK 18639860
23. A. Galor R. Margolis O.M. Brasil, et al. 2007 Adverse events after intravitreal triamcinolone in patients with and without uveitis Ophthalmology 114 1912 1918 10.1016/j.ophtha.2007.05.037 17908594 (Pubitemid 47483933)
24. D.J. Rhee R.E. Peck J. Belmont, et al. 2006 Intraocular pressure alterations following intravitreal triamcinolone acetonide Br J Ophthalmol 90 999 1003 10.1136/bjo.2006.090340 1:STN:280:DC%2BD28vivFWgsQ%3D%3D 16597664 (Pubitemid 44140181)
25. K. Hirooka F. Shiraga S. Tanaka, et al. 2006 Risk factors for elevated intraocular pressure after trans-tenon retrobulbar injections of triamcinolone Jpn J Ophthalmol 50 235 238 10.1007/s10384-005-0306-9 1:CAS:528: DC%2BD28XmvV2ntbk%3D 16767378 (Pubitemid 43881998)